|1,700||estimated jobs specialized in research and development|
|$300||CDN million estimated in sales figures|
Data compiled for the Québec City metropolitan region
As a hub for world research and expertise, the Québec City metropolitan region is an incubator for new and modern techniques that revolutionize vaccines, research and diagnostics.
Most biopharmaceutical companies in Québec City's metropolitan region are spinoffs from research conducted at the Université Laval. The technological platforms developed in its laboratories (genomics, proteomics, biocomputing, biochips and microchips) testify to the quality of its laboratory research.
Diseases such as bird flu or swine flu, colon cancer, diabetes, morbid obesity, cardiovascular metabolic syndrome and schizophrenia can be successfully diagnosed and treated, thanks to innovations from Québec. Some other major breakthroughs include:
Biopharmaceutical companies in the Québec City metropolitan region are distinguished in a number of areas. Each of these business sectors is comprised of leaders and SMEs (small- and medium-sized businesses):